ENCAPSULATE INC. — National Aeronautics and Space Administration SBIR Phase I: FY24 SBIR PHASE I- NVASIVE: UNRAVELING THE ENIGMA OF METASTASIS
ENCAPSULATE INC. — SBIR Phase I award from National Aeronautics and Space Administration.
Phase I SBIR feasibility signal
- Phase I awards fund proof-of-concept work. For capture teams, they mark early interest from National Aeronautics and Space Administration in a technical approach.
- Watch for Phase II follow-ons from the same firm/topic family — that conversion path is where budgets and transition pressure rise.
- Obligated amount $156,494. Cross-check similar awards in the same agency and technology tags for going-rate context.
- Tagged technology areas: Human Performance & Medical. Follow those hubs for open topics and peer winners in the same cluster.
Summary
Encapsulate Inc. won a NASA SBIR Phase I award of $156,494 to develop NVASIVE, a project focused on understanding how cancer spreads through metastasis. The work aims to create new tools or methods that could help study this process, potentially benefiting future medical or space health applications.
- Amount
- $156,494
- Agency
- National Aeronautics and Space Administration · National Aeronautics and Space Administration
- Program / Phase
- SBIR · Phase I
- NAICS
- 541715 · RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
- Place of performance
- CT
- Period
- 2024-08-07 → 2025-02-06
Technology domains
Description
FY24 SBIR PHASE I- NVASIVE: UNRAVELING THE ENIGMA OF METASTASIS